Rare diseases
Investigational molecules
Locations
Back to Poland51 clinical trials in Bytom, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study of Peresolimab for Adults with Moderate to Severe Rheumatoid Arthritis
PolandPhase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus
PolandStudy of SAR441566 and methotrexate in adults with moderate to severe rheumatoid arthritis
PolandStudy of AMG 193 tablets for patients with advanced non-small cell lung cancer (NSCLC) who have previously received treatment and have MTAP gene deletion
PolandStudy of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before
PolandStudy on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy
PolandStudy of GLPG3667 for Adults with Active Systemic Lupus Erythematosus
PolandStudy on the Effects of MORF-057 for Adults with Moderate to Severe Ulcerative Colitis
PolandStudy on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis
PolandStudy of Oral NX-13 for Patients with Moderate to Severe Ulcerative Colitis
PolandStudy on the Safety and Effectiveness of ESK-001 for Adults with Systemic Lupus Erythematosus
PolandTulisokibart in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
PolandThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on systemic lupus erythematosus treatments, including studies of innovative therapies like litifilimab and ianalumab. Multiple trials are evaluating new approaches to managing psoriatic arthritis and plaque psoriasis.
Studies aim to improve disease management and patient outcomes through targeted therapies.
Innovative research into inflammatory bowel diseases, with particular focus on Crohn's disease and ulcerative colitis treatments. Studies are evaluating novel compounds like obefazimod and NX-13 for therapeutic efficacy.
Trials emphasize both symptom management and disease modification approaches.
Studies addressing knee osteoarthritis and related conditions, including innovative approaches combining weight management with joint health treatments. Research includes evaluation of new immunotherapy options.
Focus on developing treatments that improve mobility and reduce pain.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
